Brett A. Giffin is Chief Commercial Officer of T2 Biosystems, Inc.. Currently has a direct ownership of 77 shares of TTOO, which is worth approximately $65. The most recent transaction as insider was on Feb 20, 2024, when has been sold 13 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 77
0% 3M change
90.84% 12M change
Total Value Held $65

Brett A. Giffin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 20 2024
BUY
Exercise of conversion of derivative security
-
13 Added 14.44%
77 Common Stock
Nov 08 2023
BUY
Exercise of conversion of derivative security
-
33 Added 34.02%
64 Common Stock
Feb 22 2023
SELL
Open market or private sale
$349 $0.65 p/Share
537 Reduced 38.97%
841 Common Stock
Feb 20 2023
BUY
Exercise of conversion of derivative security
-
1,333 Added 49.17%
1,378 Common Stock
Nov 10 2022
SELL
Open market or private sale
$2,312 $1.79 p/Share
1,292 Reduced 36.45%
2,253 Common Stock
Nov 08 2022
BUY
Exercise of conversion of derivative security
-
3,333 Added 48.46%
3,545 Common Stock
Apr 08 2022
BUY
Open market or private purchase
$5,194 $0.49 p/Share
10,600 Added 50.0%
10,600 Common Stock
BAG

Brett A. Giffin

Chief Commercial Officer
Lexington, MA

Track Institutional and Insider Activities on TTOO

Follow T2 Biosystems, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TTOO shares.

Notify only if

Insider Trading

Get notified when an T2 Biosystems, Inc. insider buys or sells TTOO shares.

Notify only if

News

Receive news related to T2 Biosystems, Inc.

Track Activities on TTOO